Also, BC resulted more effective at 400 mg/kg than 200 mg/kg on IL-1β and IFN-ƴ at 14 days (§§p < 0.01 and §p < 0.05), while, after 28 days of treatment for all three cytokines evaluated here, the two treatments similarly reduced the pro-inflammatory mediators. This evidence concerns the gene IL1B and breast cancer.